Pulsed Field Ablation for Atrial Fibrillation
- PMID: 37427302
- PMCID: PMC10326665
- DOI: 10.15420/aer.2022.45
Pulsed Field Ablation for Atrial Fibrillation
Abstract
Catheter ablation is a widely used, effective and safe treatment for AF. Pulsed field ablation (PFA), as a novel energy source for cardiac ablation, has been shown to be tissue selective and is expected to decrease damage to non-cardiac tissue while providing high efficacy in pulmonary vein isolation. The FARAPULSE ablation system (Boston Scientific) follows the idea of single-shot ablation and is the first device approved for clinical use in Europe. Since its approval, multiple high-volume centres have performed increasing numbers of PFA procedures in patients with AF and have published their experiences. This review summarises the current clinical experience regarding the use of PFA for AF using the FARAPULSE system. It provides an overview of its efficacy and safety.
Keywords: AF; catheter ablation; pulmonary vein isolation; pulsed field ablation; review.
Copyright © 2023, Radcliffe Cardiology.
Conflict of interest statement
Disclosure: KRJC is on the Arrhythmia & Electrophysiology Review editorial board; this did not influence peer review. All other authors have no conflicts of interest to declare.
Figures
References
Publication types
LinkOut - more resources
Full Text Sources
Medical
